Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 4, 2010, Pages 247-257

  Wagner, Gerd ^a   Koch, Kathrin ^a   Schachtzabel, Claudia ^a   Sobanski, Thomas ^a   Reichenbach, Jürgen R ^a   Sauer, Heinrich ^a   Schlösser, Ralf G M ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; REBOXETINE; ADRENERGIC RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE; OXYGEN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; OXYGEN BLOOD LEVEL; PREDICTION; TASK PERFORMANCE; TREATMENT OUTCOME; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD; BRAIN; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; IMAGE PROCESSING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANALYSIS OF VARIANCE; BRAIN; CITALOPRAM; COGNITION; DEPRESSIVE DISORDER; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MORPHOLINES; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954685898     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: 10.1503/jpn.090081     Document Type: Article

References (39)

1. Drevets WC, Price JL, Furey ML. Brain structural and functionalabnormalities in mood disorders: implications for neurocircuitrymodels of depression. Brain Struct Funct 2008;213:93-118.
2. Berton O, Nestler EJ. New approaches to antidepressant drug dis-covery: beyond monoamines. Nat Rev Neurosci 2006;7:137-51.
3. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-termoutcomes in depressed outpatients requiring one or several treat-ment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17.
4. Drevets WC, Bogers W, Raichle ME. Functional anatomical corre-lates of antidepressant drug treatment assessed using PET mea-sures of regional glucose metabolism. Eur Neuropsychopharmacol 2002;12:527-44.
5. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brainglucose metabolism measured with positron emission tomographyafter paroxetine treatment of major depression. Am J Psychiatry 2001;158:899-905.
6. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effectsof fluoxetine in major depression: serial changes and relationshipto clinical response. Biol Psychiatry 2000;48:830-43.
7. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changesin major depressive disorder from preto post-treatment withparoxetine. Psychiatry Res 1999;91:127-39.
8. Holthoff VA, Beuthien-Baumann B, Zundorf G, et al. Changes inbrain metabolism associated with remission in unipolar major de-pression. Acta Psychiatr Scand 2004;110:184-94.
9. Buchsbaum MS, Wu J, Siegel BV, et al. Effect of sertraline on regionalmetabolic rate in patients with affective disorder. Biol Psychiatry 1997;41:15-22.
10. Walsh ND, Williams SC, Brammer MJ, et al. A longitudinal func-tional magnetic resonance imaging study of verbal working mem-ory in depression after antidepressant therapy. Biol Psychiatry 2007;62:1236-43.
11. Fu CH, Williams SC, Cleare AJ, et al. Attenuation of the neural re-sponse to sad faces in major depression by antidepressant treatment:a prospective, event-related functional magnetic resonance imagingstudy. Arch Gen Psychiatry 2004;61:877-89.
12. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function indepression: a potential predictor of treatment response. Neuroreport 1997;8:1057-61.
13. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cin-gulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001;158:405-15.
14. Wagner G, Sinsel E, Sobanski T, et al. Cortical inefficiency in pa-tients with unipolar depression: an event-related fMRI study withthe Stroop task. Biol Psychiatry 2006;59:958-65.
15. Sara SJ. The locus coeruleus and noradrenergic modulation of cog-nition. Nat Rev Neurosci 2009;10:211-23.
16. Eriksson E. Antidepressant drugs: Does it matter if they inhibit thereuptake of noradrenaline or serotonin? Acta Psychiatr Scand Suppl 2000;402:12-7.
17. Wittchen HU, Zaudig M, Fydrich T. SKID - Strukturiertes Klinis-ches Interview für DSM IV. Achse I und II. Göttingen (Germany):Hogrefe; 1997.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychi-atry 1960;23:56-62.
19. Horn W. Leistungsprüfsystem (LPS). Göttingen (Germany): Hogrefe;1983.
20. Reitan RM. The relation of the trail making test to organic braindamage. J Consult Psychol 1955;19:393-4.
21. Franke G. Die Symptomcheckliste von Derogatis - Deutsche Version. Göttingen (Germany): Beltz Test; 1995.
22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuringdepression. Arch Gen Psychiatry 1961;4:561-71.
23. Briggs GG, Nebes RD. Patterns of hand preference in a studentpopulation. Cortex 1975;11:230-8.
24. Hayasaka S, Phan KL, Liberzon I, et al. Nonstationary cluster-sizeinference with random field and permutation methods. Neuroimage 2004;22:676-87.
25. Davidson RJ, Irwin W, Anderle MJ, et al. The neural substrates ofaffective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003;160:64-75.
26. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala re-sponse to masked emotional faces in depressed subjects resolveswith antidepressant treatment: an fMRI study. Biol Psychiatry 2001;50:651-8.
27. Harmer CJ. Serotonin and emotional processing: Does it help ex-plain antidepressant drug action? Neuropharmacology 2008;55:1023-8.
28. Harmer CJ, Mackay CE, Reid CB, et al. Antidepressant drug treat-ment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59:816-20.
29. Arce E, Simmons AN, Lovero KL, et al. Escitalopram effects on in-sula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008;196:661-72.
30. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus med-ication for depression: treatment outcomes and neural mecha-nisms. Nat Rev Neurosci 2008;9:788-96.
31. Logan J, Wang GJ, Telang F, et al. Imaging the norepinephrinetransporter in humans with (S,S)-[11C]O-methyl reboxetine andPET: problems and progress. Nucl Med Biol 2007;34:667-79.
32. Smith HR, Beveridge TJ, Porrino LJ. Distribution of norepinephrinetransporters in the non-human primate brain. Neuroscience 2006;138:703-14.
33. Varnas K, Halldin C, Hall H. Autoradiographic distribution ofserotonin transporters and receptor subtypes in human brain. HumBrain Mapp 2004;22:246-60.
34. Yasuno F, Suhara T, Nakayama T, et al. Inhibitory effect of hippo-campal 5-HT1A receptors on human explicit memory. Am J Psychiatry 2003;160:334-40.
35. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacyand acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373:746-58.
36. Little JT, Ketter TA, Kimbrell TA, et al. Bupropion and venlafaxineresponders differ in pretreatment regional cerebral metabolism inunipolar depression. Biol Psychiatry 2005;57:220-8.
37. Marcus SM, Young EA, Kerber KB, et al. Gender differences in depres-sion: findings from the STAR*D study. J Affect Disord 2005;87:141-50.
38. Wagner G, Koch K, Schachtzabel C, et al. Enhanced rostral ante-rior cingulate cortex activation during cognitive control is relatedto orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 2008;33:199-208.
39. Manji HK, Drevets WC, Charney DS. The cellular neurobiology ofdepression. Nat Med 2001;7:541-7.